Piperidine derivatives as melanocortin4 receptor agonists

Details for Australian Patent Application No. 2004259717 (hide)

Owner Merck & Co., Inc.

Inventors Ujjainwalla, Feroze; Sings, Heather

Agent Spruson & Ferguson

Pub. Number AU-A-2004259717

PCT Pub. Number WO2005/009950

Priority 60/489,313 22.07.03 US

Filing date 16 July 2004

Wipo publication date 3 February 2005

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/454 (2006.01)

A61K 31/4545 (2006.01)

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/009950 Priority application(s): WO2005/009950

15 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004259727-Eimeria tenella antigen for immunotherapy of coccidiosis

2004259716-Method for making a thin die to be used in a press